본문 바로가기 대메뉴 바로가기
Noh, Woo Chul(Professor)

INFO

  • AffiliationKorea Institute of Radiological & Medical Sciences
  • Majors Radiological & Medico-Oncological Sciences
  • Contact Information02-970-1221
  • Major
  • Highest Level of Education
  • E-Mail

Field of Research

The examination of ovarian reserve in premenopausal patients eith hormone receptor positive breast cancer

Research Results

-  Targeting HIF-1a is a prerequisite for cell sensitvity to dichloroacetate(DCA) and metformin -  Prognostic Value of Anti-Mullerian Hormone and Inhibin B in Parients with Premenopausal Hormone Receptor-psitive Breast Cancer -  Inhibition of S6K1 enhances glucose deprivation-induced cell death via downreglulation of anti_appototic in MCF-7 breast cancer cell

Treatise

-  TRAIL restores DCA/metformin-mediated cell death in hypoxia[ BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,2016-09-23] -  Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor[ ONCOTARGET,2016-08-01] -  Melatonin Enhances Arsenic Trioxide-Induced Cell Death via Sustained Upregulation of Redd1 Expression in Breast Cancer Cells[ MOLECULAR AND CELLULAR ENDOCRINOLOGY,2016-02-15] -  Targeting HIF-1a is a prerequisite for cell sensitivity to dichloroacetate(DCA) and metformin[ BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,2016-01-08] -  Prognostic Value of Anti-Mullerian Hormone and Inhibin B in Patients with Premenopausal Hormone Receptor-positive Breast Cancer[ ANTICANCER RESEARCH,2016-03-01] -  STAT3-Survivin signaling modulates poor response to radiotherapy in HER2-positive breast cancer[ ONCOTARGET,2016-02-09] -  The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress[ BMC CANCER,2016-05-19] -  S6K1 inhibition enhances the apoptotic cell death of breast cancer cells in respinse to Bcl-2.Bcl-xL inhibition by the downregulation of survivin[ ONCOLOGY LETTERS,2016-08-01] -  Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literature[ JOURNAL OF SURGICAL ONCOLOGY,2015-08-01] -  Inhibition of S6K1 enhances dichloroacetate-induced cell death[ JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY,2015-07-01] -  Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells[ JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY,2014-12-01] -  The combination of FDG PET and dynamic contrast-enhanced MRI improved the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy[ EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,2014-06-14] -  Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients[ JOURNAL OF BREAST CANCER,2014-03-28] -  Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer[ BREAST CANCER RESEARCH AND TREATMENT,2015-02-05] -  Serum human epidermal growth factor receptor 2 levels as a real-time marker for tumor burden in breast cancer patients[ JOURNAL OF SURGICAL ONCOLOGY,2014-04-01] -  The Effect of Reproductive Factors on Breast Cancer Presentation in Women Who Are BRCA Mutation Carrier[ JOURNAL OF BREAST CANCER,2017-09-20] -  Core Needle Biopsy Specimens Are More Appropriate than Surgical Specimens for Evaluating the Expression of Phosphoproteins as Biological Markers in Invasive Breast Cancer[ ANTICANCER RESEARCH,2017-03-01] -  The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase 18F-FDG PET/CT[Nuclear Medicine and Molecular Imaging ,2016-09-30]